Literature DB >> 9379007

Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation.

K C Herold1, J Lu, I Rulifson, V Vezys, D Taub, M J Grusby, J A Bluestone.   

Abstract

C-C chemokines play an important role in recruitment of T lymphocytes to inflammatory sites. T lymphocytes secrete chemokines, but the activation requirements for chemokine production by T cells are uncertain. We studied the regulation of C-C chemokine production by CD28 costimulatory signals by murine T lymphocytes. Splenocytes from BALB/c mice cultured with anti-CD3 mAb expressed macrophage-inflammatory protein (MIP)-1alpha mRNA and secreted MIP-1alpha, which was inhibited by anti-B7-1 plus anti-B7-2 mAbs. MIP-1alpha production by Ag-stimulated T cells from DO.11.10 TCR transgenic mice was augmented by anti-CD28 mAb and increased compared with DO.11.10/CD28(-/-) cells. When T cell costimulation was provided by IL-2, MIP-1alpha was not enhanced. Studies with IL-2, IL-4, STAT4, and STAT6 knock-out mice suggested that chemokine production is controlled by pathways different from those regulating T cell differentiation. Thus, CD28 costimulation may amplify an immune response by stimulating T cell survival, proliferation, and production of chemokines that recruit T cells to inflammatory sites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379007

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  CD28-independent induction of experimental autoimmune encephalomyelitis.

Authors:  T Chitnis; N Najafian; K A Abdallah; V Dong; H Yagita; M H Sayegh; S J Khoury
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 2.  Chemokines: understanding their role in T-lymphocyte biology.

Authors:  S G Ward; J Westwick
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

3.  Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.

Authors:  A Chandraker; H Azuma; K Nadeau; C B Carpenter; N L Tilney; W W Hancock; M H Sayegh
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

Review 4.  Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.

Authors:  Frank Waldron-Lynch; Kevan C Herold
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

Review 5.  Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis.

Authors:  K J Kennedy; W J Karpus
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

6.  Naïve and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implicatip6s for transmission and pathogenesis.

Authors:  J L Riley; B L Levine; N Craighead; T Francomano; D Kim; R G Carroll; C H June
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunity.

Authors:  Jens Eberlein; Bennett Davenport; Tom T Nguyen; Francisco Victorino; Tim Sparwasser; Dirk Homann
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

Review 8.  Modulating co-stimulation.

Authors:  Vissia Viglietta; Samia J Khoury
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

9.  Distinct in vivo roles of CD80 and CD86 in the effector T-cell responses inducing antigen-induced arthritis.

Authors:  Dragana Odobasic; Michelle T Leech; Jin R Xue; Stephen R Holdsworth
Journal:  Immunology       Date:  2008-01-24       Impact factor: 7.397

10.  Mechanism of reduced T-cell effector functions and class-switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulation.

Authors:  Lydia G Thebeau; Lynda A Morrison
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.